AstraZeneca and MedImmune are committed to supporting quality independent education that:

  • Meet an educational need by providing information designed to assist health care professionals in their efforts to enhance patient care
  • Further the understanding of emerging therapies based on a documented unmet need
  • Incorporate evidence-based medicine in the program objectives and methodology
  • Assist health care professionals in carrying out diagnosis and treatment strategies more effectively and efficiently
  • Support the efforts of health care professionals to broaden patient knowledge and awareness of disease states and treatment options
  • Address performance and quality improvement

We focus our support where there is the greatest need in areas that overlap with our areas of interest.

We have incorporated Call for Grant Applications into our process. Please check available Call for Grants below.

Available funding for areas of educational interest

No funding available - check back periodically

Areas of Educational Interest Available Funding Call for Grants
Acute Coronary Syndrome    
High Risk Prior Myocardial Infarction    
Heart Failure - SGLT2 Inhibition    
Type 1 Diabetes    
Type 2 Diabetes    
Type 2 Diabetes – Heart Failure    
Type 2 Diabetes – Chronic Kidney Disease    
Research & Development Support    
Chronic Kidney Disease – Anemia
Chronic Kidney Disease – SGLT2 Inhibition  
Advanced Breast Cancer    
  • BRCA
  • Non-BRCA
  • DNA Damage Response
  • PARP inhibition
  • HER2+
  • Metastatic HR+
Ovarian Cancer    
  • BRCA
  • Non-BRCA
  • PARP inhibition
  • DNA Damage Response
  • CLL (Chronic Lymphocytic Leukemia)
  • MCL (Mantle Cell Lymphoma)
  • HCL (Hairy Cell Leukemia)
  • WM (Waldenstrom Macroglobulinemia)
  • Bladder
  • imAE Management
  • Extensive-Stage SCLC
  • Non-Metastatic NSCLC
  • HCC (Hepatocellular Carcinoma)
  • IO Diagnostics – Multidisciplinary Team
  • IO Lung Diagnostics – Staging
Non Small Cell Lung Cancer    
  • EGFR – Multidisciplinary Team
  • EGFR Diagnostics – Staging
  • EGFR Diagnostics - Tissue Collection
  • EGFR Diagnostics - Plasma Testing
  • EGFR T790m+ NSCLC
Pancreatic Cancer    
  • BRCA
  • DNA Damage Response
  • PARP Inhibition
Prostate Cancer (mCRPC)    
  • DNA Damage Response
  • Homologus Recombination Repair
  • PARP inhibition
COPD (Limited US Budget)    
Chronic Cough (EX-US only)    
Asthma – EX-US only    
Severe Asthma (Limited US Budget)    
Systemic Lupus Erythematosus    
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities